The effects of chromium picolinate and chromium histidinate administration on NF-κB and Nrf2/HO-1 pathway in the brain of diabetic rats

Biological Trace Element Research

Volumn 150, Issue 1-3, 2012, Pages 291-296

  Sahin, Kazim ^a   Tuzcu, Mehmet ^a   Orhan, Cemal ^a   Gencoglu, Hasan ^a   Ulas, Mustafa ^a   Atalay, Mustafa ^b   Sahin, Nurhan ^a   Hayirli, Armagan ^c   Komorowski, James R ^d  

^a FIRAT UNIVERSITY   (Turkey)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c ATATÜRK UNIVERSITY   (Turkey)

^d Nutrition 21 Inc   (United States)

Author keywords

Chromium picolinate histidinate; I B ; NF B p65; Nrf2

Indexed keywords

4 HYDROXYNONENAL; CHROMIUM DERIVATIVE; CHROMIUM HISTIDINATE; CHROMIUM PICOLINATE; DRINKING WATER; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME INHIBITION; FAT INTAKE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; SUPPLEMENTATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CHELATING AGENTS; CHROMIUM; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HEME OXYGENASE (DECYCLIZING); HISTIDINE; HYPOGLYCEMIC AGENTS; I-KAPPA B PROTEINS; MALE; NERVE TISSUE PROTEINS; NEURONS; NF-E2-RELATED FACTOR 2; ORGANOMETALLIC COMPOUNDS; PICOLINIC ACIDS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

RATTUS; RATTUS NORVEGICUS;

EID: 84870680299     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9475-9     Document Type: Article

References (37)

1. Feldman EL, Russell JW, Sullivan KA, Golovoy D (1999) New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol 12:553-563
2. Biessels GJ, Kamal A, Urban IJ, Spruijt BM et al (1998) Water maze learning and hippocampal synaptic plasticity in streptozotocin diabetic rats: effects of insulin treatment. Brain Res 800:125-135
3. Vincent AM, Edwards JL, Sadidi M, Feldman EL (2008) The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets 9:94-100
4. Kumar A, Negi G, Sharma SS (2011) JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes Obes Metab 13:750-758
5. Cameron NE, Cotter MA (2008) Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets 9:94-100
6. Meunier A, Latrémolière A, Dominguez E et al (2007) Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther 15:687-697
7. Kim J, Cha YN, Surh YJ (2010) A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 690:12-23
8. Negi G, Kumar A, Joshi RP, Sharma SS (2011) Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem Biophys Res Commun 408:1-5
9. Yoh K, Hirayama A, Ishizaki K et al (2008) Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 13:1159-1170
10. Negi G, Kumar A, Sharma SS (2011) Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades. J Pineal Res 50:124-131
11. Vincent JB (2010) Chromium: celebrating 50 years as an essential element? Dalton Trans 39:3787-3794
12. Di Bona KR, Love S, Rhodes NR, McAdory D et al (2011) Chromium is not an essential trace element for mammals: effects of a low-chromium diet. J Biol Inorg Chem 16:381-390
13. Wallach S (1985) Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr 4:107-120
14. Faure P, Roussel A, Coudray C et al (1992) Zinc and insulin sensitivity. Biol Trace Elem Res 32:305-310
15. Becker DJ, Reul B, Ozcelikay AT et al (1996) Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeagenic enzymes in diabetic rats. Diabetologia 39:3-11
16. Sahin K, Onderci M, Tuzcu M et al (2007) Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 56:1233-1240
17. Ding W, Chai Z, Duan P et al (1998) Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res 63:231-237
18. Cefalu WT, Wang ZQ, Zhang XH et al (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 132:1107-1114
19. Anderson RA, Polansky MM, Bryden NA (2004) Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol Trace Elem Res 101:211-218
20. Häcker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006(357):re13
21. Reed MJ, Meszaros K, Entes LJ (2000) A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49:1390-1394
22. Farombi EO, Shrotriya S, Na HK et al (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46:1279-1287
23. SAS, User's Guide (2002) Statistics, version 9. Statistical Analysis System. SAS Inst., Inc., Cary, NC
24. Jain SK, Lim G (2006) Chromium chloride inhibits TNF-α and IL-6 secretion in isolated human blood monoclear cells exposed to high glucose. Horm Metab Res 38:60-62
25. Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-a, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43:1124-1131
26. Figueroa-Romero C, Sadidi M, Feldman EL (2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 9:301-314
27. Acharyya S, Villalta SA, Bakkar N et al (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117:889-901
28. Zhang X, Zhang G, Zhang H et al (2008) Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135:61-73
29. Tuzcu M, Sahin N, Orhan C et al (2011) Impact of chromium histidinate on high fat diet induced obesity in rats. Nutr Metab (Lond) 3:8-28
30. Russell JW, Golovoy D, Vincent AM et al (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16:38-48
31. Sima AA, Sugimoto K (1999) Experimental diabetic neuropathy: an update. Diabetologia 42:773-788
32. Akude E, Zherebitskaya E, Roy Chowdhury SK et al (2010) 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res 17:28-38
33. Ishii T, Itoh K, Ruiz E et al (2004) Role of nrf2 in the regulation of cd36 and stress protein expression in murine macrophages activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94:609-616
34. Obrosova IG, Drel VR, Pacher P et al (2005) Oxidative-nitrosative stress and poly (ADPribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54:3435-3441
35. Obrosova IG, Ilnytska O, Lyzogubov VV et al (2007) High-fat diet induced neuropathy of pre-diabetes and obesity: effects of healthy diet and aldose reductase inhibition. Diabetes 56:2598-2608
36. Praticò D, Tangirala RK, Rader DJ et al (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in Apo E-deficient mice. Nat Med 4:1189-1192
37. Preuss HG, Grojec PL, Lieberman S, Anderson RA (1997) Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol 47:325-330